## **Core Concept**
The **MDR (Multidrug Resistance) gene**, also known as **MDR1** or **ABCB1**, encodes for a protein called P-glycoprotein (P-gp). This protein plays a critical role in drug resistance by affecting the pharmacokinetics of various drugs. P-glycoprotein acts as an efflux transporter.

## **Why the Correct Answer is Right**
The correct answer, **D. Increasing efflux of drugs out of cells**, is right because P-glycoprotein, encoded by the MDR gene, functions by binding to and transporting a wide variety of drugs out of cells. This efflux mechanism reduces the intracellular concentration of drugs, thereby decreasing their effectiveness. P-glycoprotein uses the energy from ATP hydrolysis to pump drugs across the cell membrane, effectively lowering the intracellular drug concentration.

## **Why Each Wrong Option is Incorrect**
- **Option A: Decreasing drug absorption** - This option is incorrect because while P-glycoprotein can influence drug absorption in the gut, its primary mechanism related to multidrug resistance is through efflux, not absorption.
- **Option B: Increasing drug metabolism** - This option is incorrect because the MDR gene product, P-glycoprotein, does not directly affect drug metabolism. Drug metabolism is primarily influenced by enzymes such as the cytochrome P450 family.
- **Option C: Enhancing drug binding to DNA** - This option is incorrect because P-glycoprotein's action does not involve enhancing drug binding to DNA. Its role is related to drug transport across cell membranes.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **inhibitors of P-glycoprotein** can potentially reverse multidrug resistance by blocking the efflux pump, thereby increasing the intracellular concentration of chemotherapeutic agents. This concept is crucial in oncology and pharmacology.

## **Correct Answer:** D. Increasing efflux of drugs out of cells